HOME >> BIOLOGY >> NEWS
Clemson Researchers Turn Crabshells Into New Product Lines

McCLELLANVILLE D Clemson University researchers have developed a new process to turn crab shells into natural marketable products. Food and packaging scientists Ronald L. Thomas and Robert F. Testin at Clemson are working with W.E. (Eddie) Gordon, owner of the South Carolina Crab Company in McClellanville, to process crab shells into promising new product lines.

"Ninety percent of the shellfish is discarded in traditional seafood processing operations around the world," Thomas said. "We've developed a process to completely eliminate that and use 100 percent of the product."

The process is a closed-loop system that extracts the remainder of food-grade meat from the shells, then reduces the shells to their primary materials D chitin and calcium D with no discharge into the environment. The chitin can then be converted into chitosan and glucosamine, products that are in high demand by the food supplement industry, the medical profession, manufacturing and agriculture.

The food supplement, or nutraceutical industry, sells glucosamine as a treatment for chronic arthritis and chitosan as a natural fiber for reducing cholesterol and absorbing fat. Physicians use chitosan film as an "artificial skin" to treat burns and severe wounds because of its antimicrobial properties. Manufacturers use chitosan as a natural polymer to remove heavy metals from industrial waste water. Agriculture uses chitosan as a feed supplement for hogs and as a seed coating. The cosmetic industry uses it in shampoos and face creams.

"Chitin is the second most abundant natural polymer in the world after cellulose," Thomas said. "We're just beginning to explore all its possible applications."

Gordon's South Carolina Crab Company is developing a prototype system to process food-grade chitin, calcium and crab meat from the shells. The system is currently undergoing testing and refinements, with the possibility of commercial application t
'"/>

Contact: Ron Thomas
rthms@clemson.edu
864-656-5697
Clemson University
18-Dec-1998


Page: 1 2

Related biology news :

1. Clemson University spin-off uses corn to make plastics, provide cleaner air
2. Clemson researcher places hope on pushy photons
3. Clemson researcher receives Komen grant
4. Clemson University researcher reaches for the stars to prevent osteoporosis
5. Clemson launches S.C. DNA Learning Center
6. Clemson dedicates biotech research complex
7. Breakthrough Clemson research appears in Science
8. Clemson researcher takes part in breakthrough research on insects
9. Clemson researchers find bacteria fighter that does not promote bacterial resistance
10. Clemson researchers identify mental retardation gene
11. Clemson researchers create biosensors to protect nations food and water supplies

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/2/2016)... The Department of Transport Management (DOTM) of ... Dollar project, for the , Supply and Delivery ... IT Infrastructure , to Decatur ... Identity Management Solutions. Numerous renowned international vendors participated in the ... was selected for the most compliant and innovative solution. The ...
(Date:5/24/2016)... patient care by providing unparalleled technology to leaders of the medical imaging industry.  As ... added to the range of products distributed by Ampronix. Photo - ... ... ... ...
(Date:5/9/2016)... Elevay is currently known as ... for high net worth professionals seeking travel for work ... world, there is still no substitute for a face-to-face ... your deal with a firm handshake. This is why ... of citizenship via investment programs like those offered by ...
Breaking Biology News(10 mins):
(Date:6/24/2016)... ... ... While the majority of commercial spectrophotometers and fluorometers use the z-dimension of ... higher end machines that use the more unconventional z-dimension of 20mm. Z-dimension ... of the cuvette holder. , FireflySci has developed several Agilent flow cell product ...
(Date:6/23/2016)... June 23, 2016 /PRNewswire/ - FACIT has announced ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" ... commercialization of a portfolio of first-in-class WDR5 inhibitors ... such as WDR5 represent an exciting class of ... precision medicine for cancer patients. Substantial advances have ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... 23, 2016 Apellis Pharmaceuticals, Inc. today ... trials of its complement C3 inhibitor, APL-2. The ... ascending dose studies designed to assess the safety, ... injection in healthy adult volunteers. Forty ... a single dose (ranging from 45 to 1,440mg) ...
Breaking Biology Technology:
Cached News: